Pharma-Bio Serv (PBSV) Liabilities and Shareholders Equity (2010 - 2026)
Pharma-Bio Serv posted quarterly Liabilities and Shareholders Equity of $13.5 million for Q1 2026, down 15.73% year-on-year from $16.1 million in Q1 2025, and down 0.77% on a QoQ basis from $13.7 million in Q4 2025.
Pharma-Bio Serv (PBSV) has 16 years of Liabilities and Shareholders Equity data on file, last reported at $13.5 million in Q1 2026.
- For the quarter ending Q1 2026, Liabilities and Shareholders Equity fell 15.73% year-over-year to $13.5 million; the trailing twelve-month figure through Jan 2026 stood at $54.7 million (down 16.65% YoY), and the FY2025 full-year result was $13.7 million, down 16.2% from the prior year.
- Liabilities and Shareholders Equity for Q1 2026 stood at $13.5 million, down from $13.7 million in the prior quarter.
- Across five years, Liabilities and Shareholders Equity topped out at $22.9 million in Q1 2023 and bottomed at $13.5 million in Q1 2026.
- The 5-year median for Liabilities and Shareholders Equity is $19.2 million (2024), against an average of $18.0 million.
- The widest annual swing landed in 2022, when Liabilities and Shareholders Equity declined 28.91%; it then grew 3.74% in 2023.
- A 5-year view of Liabilities and Shareholders Equity shows it stood at $20.7 million in 2022, then dropped by 3.63% to $19.9 million in 2023, then slipped by 18.14% to $16.3 million in 2024, then declined by 16.2% to $13.7 million in 2025, then dropped by 0.77% to $13.5 million in 2026.
- The last three Liabilities and Shareholders Equity figures came in at $13.5 million (Q1 2026), $13.7 million (Q4 2025), and $13.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | 8.98 Bn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | 6.21 Bn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | 3.31 Bn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | 728.77 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | 1.12 Bn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | 5.84 Bn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | 1.02 Bn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | 1.42 Bn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | 2.00 Bn |
| 10 | Pharma-Bio Serv | - | - | 722,374.00 | 13.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 13.55 Mn |
| Oct 31, 2025 | 13.65 Mn |
| Jul 31, 2025 | 13.59 Mn |
| Apr 30, 2025 | 13.90 Mn |
| Jan 31, 2025 | 16.08 Mn |
| Oct 31, 2024 | 16.29 Mn |
| Jul 31, 2024 | 16.32 Mn |
| Apr 30, 2024 | 16.92 Mn |
| Jan 31, 2024 | 19.23 Mn |
| Oct 31, 2023 | 19.90 Mn |
| Jul 31, 2023 | 20.30 Mn |
| Apr 30, 2023 | 19.62 Mn |
| Jan 31, 2023 | 22.90 Mn |
| Oct 31, 2022 | 20.65 Mn |
| Jul 31, 2022 | 20.33 Mn |
| Apr 30, 2022 | 20.16 Mn |
| Jan 31, 2022 | 22.07 Mn |
| Oct 31, 2021 | 23.92 Mn |
| Jul 31, 2021 | 28.59 Mn |
| Apr 30, 2021 | 27.90 Mn |
| Jan 31, 2021 | 30.20 Mn |
| Oct 31, 2020 | 29.92 Mn |
| Jul 31, 2020 | 30.10 Mn |
| Apr 30, 2020 | 28.64 Mn |
| Jan 31, 2020 | 26.16 Mn |
| Oct 31, 2019 | 26.63 Mn |
| Jul 31, 2019 | 26.25 Mn |
| Apr 30, 2019 | 25.65 Mn |
| Jan 31, 2019 | 25.28 Mn |
| Oct 31, 2018 | 25.38 Mn |
| Jul 31, 2018 | 23.31 Mn |
| Apr 30, 2018 | 22.51 Mn |
| Jan 31, 2018 | 22.41 Mn |
| Oct 31, 2017 | 22.35 Mn |
| Jul 31, 2017 | 22.51 Mn |
| Apr 30, 2017 | 22.56 Mn |
| Jan 31, 2017 | 23.06 Mn |
| Oct 31, 2016 | 24.00 Mn |
| Jul 31, 2016 | 24.02 Mn |
| Oct 31, 2015 | 24.14 Mn |
| Oct 31, 2013 | 21.28 Mn |
| Apr 30, 2013 | 18.03 Mn |
| Jan 31, 2013 | 16.40 Mn |
| Oct 31, 2012 | 15.74 Mn |
| Jul 31, 2012 | 13.92 Mn |
| Apr 30, 2012 | 12.51 Mn |
| Jan 31, 2012 | 11.47 Mn |
| Oct 31, 2011 | 10.85 Mn |
| Jul 31, 2011 | 9.48 Mn |
| Oct 31, 2010 | 6.56 Mn |